<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03609333</url>
  </required_header>
  <id_info>
    <org_study_id>H16-00466</org_study_id>
    <nct_id>NCT03609333</nct_id>
  </id_info>
  <brief_title>Characterizing the cerebrovAscular Physiology of Optimal Mean Arterial Pressure Targeted Resuscitation</brief_title>
  <acronym>CAMPHIBIII</acronym>
  <official_title>Characterizing the cerebrovAscular Physiology of Optimal Mean Arterial Pressure Targeted Resuscitation in Hypoxic Ischemic Brain Injury After Cardiac Arrest</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of British Columbia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of British Columbia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hypoxic ischemic brain injury is a devastating illness that occurs after cardiac arrest (the&#xD;
      heart stopping) and can yield irreversible brain damage, often leading to death. The mainstay&#xD;
      in therapy is to optimize the delivery of oxygen to the brain to help it recover. In patients&#xD;
      with traumatic brain injury (similar to HIBI), the investigators are able to optimize oxygen&#xD;
      delivery to the brain with the use of wires placed into the brain that sense the pressure and&#xD;
      oxygen in the skull to find the ideal blood pressure for each individual patient. This&#xD;
      strategy is associated with improved outcomes. The investigators are conducting a prospective&#xD;
      study investigating whether the perfusion within proximity to the optimal MAP is associated&#xD;
      with improved brain oxygenation and blood flow .&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 12, 2016</start_date>
  <completion_date type="Actual">June 30, 2020</completion_date>
  <primary_completion_date type="Actual">June 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
  </study_design_info>
  <primary_outcome>
    <measure>Cerberal blood flow</measure>
    <time_frame>12 hours</time_frame>
    <description>mls/100g/min</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Cardiac Arrest</condition>
  <arm_group>
    <arm_group_label>Internal arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Multimodal Neuromonitoring</intervention_name>
    <description>Application of multimodal neuromonitoring</description>
    <arm_group_label>Internal arm</arm_group_label>
    <other_name>Targeted optimal MAP resuscitation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Confirmed cardiac arrest with return of spontaneous circulation &gt; 10 minutes&#xD;
&#xD;
          -  post resuscitation GCS &lt; 9&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  concurrent coagulopathy&#xD;
&#xD;
          -  prior history of TBI, intracranial hemorrhage, subarachnoid hemorrhage&#xD;
&#xD;
          -  anticipated cardiac catheterization within next 7 days&#xD;
&#xD;
          -  anticipated or current use of anticoagulants or anit-platelets&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mypinder Sekhon, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UBC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Vancouver General Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V5Z 1M9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>July 25, 2018</study_first_submitted>
  <study_first_submitted_qc>July 25, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 1, 2018</study_first_posted>
  <last_update_submitted>November 2, 2020</last_update_submitted>
  <last_update_submitted_qc>November 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 3, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of British Columbia</investigator_affiliation>
    <investigator_full_name>Myp Sekhon</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Arrest</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

